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Abstract
Large data volumes have been collected by healthcare organizations at an un-
precedented rate. Today both physicians and healthcare system managers are
very interested in extracting value from such data. Nevertheless, the increas-
ing data complexity and heterogeneity prompts the need for new efficient and
effective data mining approaches to analyzing large patient datasets. Gener-
alized association rule mining algorithms can be exploited to automatically
extract hidden multiple-level associations among patient data items (e.g.,
examinations, drugs) from large datasets equipped with taxonomies. How-
ever, in current approaches all data items are assumed to be equally relevant
within each transaction, even if this assumption is rarely true.
This paper presents a new data mining application targeted to patient
data analysis. It tackles the issue of extracting generalized rules from weighted
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patient data, where items may weight differently according to their impor-
tance within each transaction. To this aim, it proposes a novel type of asso-
ciation rule, namely the Weighted Generalized Association Rule (W-GAR).
The usefulness of the proposed pattern has been evaluated on real patient
datasets equipped with a taxonomy built over examinations and drugs. The
achieved results demonstrate the effectiveness of the proposed approach in
mining interesting and actionable knowledge in a real medical care scenario.
Keywords: Generalized Association Rule Mining, Weighted Data Mining,
Medical Data
1. Introduction
In today’s world large volumes of data have continuously been generated
during patient care. However, from the analysis of medical datasets low
profits can be made unless physicians and healthcare system managers be-
come able to automatically gain actionable knowledge from potentially large
data collections. Patient data analysis is attractive for both physicians, who
can use new automatic tools for patient care and healthcare system man-
agement, and computer scientists, who can tackle the challenging issue of
applying novel data mining techniques to real datasets characterized by an
inherent sparseness.
Data mining techniques focus on studying algorithms to find implicit,
previously unknown, and potentially useful information from data. In the
context of medical care existing data mining approaches encompass dif-
ferent analyses, such as mining underlying associations among data items
(e.g., [6, 20, 34, 38, 40]), clustering (e.g., [4, 5, 48]), and classification
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(e.g.,[26, 33]). However, the increasing complexity and heterogeneity of medi-
cal data prompts the need for novel and effective approaches to automatically
mining actionable knowledge. This knowledge can be exploited, for exam-
ple, to improve the current patient care processes, to assess new medical
guidelines, or to enrich existing ones.
In the last few years the use of exploratory techniques to discover hidden
correlations among medical data items has received great attention by the
research community. To discover valuable multiple-level correlations among
data equipped with taxonomies, generalized association rule mining tech-
niques [41] can be easily exploited. A taxonomy, i.e., a set of is-a hierarchies
that aggregate data items into higher-level concepts, is used to analyze co-
occurrences among data items at different abstraction levels. A generalized
association rule is an implication in the form A → B, where A and B are
disjoint sets of generalized items belonging to the taxonomy. The rule is
characterized by its frequency of occurrence in the dataset, which is called
support, and by the strength of the implication, called confidence.
A major drawback of traditional association rule mining approaches is
that all data items are assumed to be equally relevant within the analyzed
data, even though in many application domains this assumption is not true.
For example, in the medical context prescribed examinations and drugs have
not all the same importance in patient care. To overcome this issue, weighted
datasets can be analyzed. A weighted dataset is a dataset in which to each
item a weight, denoting its relative importance in the corresponding transac-
tion, is assigned. Some research efforts (e.g., [44, 47, 49]) have been made to
consider also item weights during the association rule mining process. How-
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ever, to the best of our knowledge, no generalized rule mining algorithm is
currently able to successfully cope with weighted data. Therefore, there is
a need for innovative solutions to discover interesting patterns at different
abstraction levels from weighted data.
The main contributions of this paper can be summarized as follows:
• It presents a new data mining application, named Weighted Patient
Data Analyzer (WeP-DatA), targeted to patient data analysis.
• It proposes a novel type of generalized association rule, namely the
Weighted Generalized Association Rule (W-GAR), tailored to weighted
data.
• It considers two different measures for weighting data items, which are
targeted to different use cases.
• As a case study, the proposed approach has been applied to the medical
care scenario to demonstrate the effectiveness of W-GARs in discover-
ing interesting and actionable knowledge on real data.
W-GARs are a new type of generalized association rules, which also con-
sider item weights during rule evaluation. W-GAR extraction entails the
typical two-step process: (i) Frequent generalized weighted itemset mining
from weighted datasets by enforcing a minimum weighted support thresh-
old minwsup, and (ii) frequent W-GAR extraction, starting from the previ-
ously mined itemsets, by enforcing a minimum weighted confidence threshold
minwconf. To filter out rules that contain irrelevant information during W-
GAR extraction, itemset occurrences within each weighted transaction are
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weighted by the least item weight. In such a way, we guarantee that all
generalized items in a W-GAR have a minimal relevance score within each
transaction.
The proposed approach has been applied to a real dataset of diabetic
patients provided by the National Health Center of an Italian province. Two
different weighting measures (i.e., simple frequency and tf-idf [32] of pre-
scriptions) were tested. The experiments demonstrate that, starting from a
large collection of raw patient weighted data, W-GARs represent interesting
multiple-level associations among patient treatments, which are hardly in-
ferable using traditional rules. The results were validated by clinical domain
experts. The extracted rules appear to be consistent with the guidelines for
diabetes disease [1, 23, 24].
This paper is organized as follows. Section 1.1 presents a motivating
example, to exemplify the main advantages of the new kind of proposed
rules in the specific context under analysis. Section 2 presents the Weighted
Patient Data Analyzer environment. Section 3 assesses the effectiveness of
the system in performing knowledge discovery from a real diabetic patient
dataset. Section 4 compares our approach with most relevant related works,
while Section 5 draws conclusions, presents future developments of this work
and envisions different use case scenarios where the newly proposed rules
may be profitability exploited to support advanced analyses.
1.1. Motivating example
Let us consider the dataset and taxonomy reported in Table 1 and Fig-
ure 1, respectively, which come from the medical domain. The dataset con-
sists of 4 transactions. Each transaction corresponds to a different patient,
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Table 1: Example of unweighted transactional dataset
Patient id Examinations and drug prescriptions
1 (Exam : Glucose) (Drug : Pantoprazole) (Drug : Acetylsalicylic Acid)
2 (Exam : Glucose) (Drug : Pantoprazole) (Drug : Moxifloxacin)
3 (Exam : Glucose) (Drug : Pantoprazole) (Drug : Acetylsalicylic Acid)
4 (Exam : Glucose) (Drug : Pantoprazole) (Drug : Moxifloxacin)
5 (Exam : Glucose) (Drug : Omeprazole) (Drug : Acetylsalicylic Acid)
Table 2: Example of weighted transactional dataset. Measure: number of prescriptions
Patient id Examinations and drug prescriptions
1 〈Exam : Glucose,6〉 〈Drug : Pantoprazole, 1〉 〈Drug : Acetylsalicylic Acid, 10〉
2 〈Exam : Glucose,2〉 〈Drug : Pantoprazole, 2〉 〈Drug : Moxifloxacin,2〉
3 〈Exam : Glucose,4〉 〈Drug : Pantoprazole, 2〉 〈Drug : Acetylsalicylic Acid, 5〉
4 〈Exam : Glucose,6〉 〈Drug : Pantoprazole, 3〉 〈Drug : Moxifloxacin,2〉
5 〈Exam : Glucose,2〉 〈Drug : Omeprazole,5〉 〈Drug : Acetylsalicylic Acid, 4〉
which is identified by the respective patient id (Pid). Transactions con-
tain the examinations undergone and the drugs prescribed to each patient
during the last year. The taxonomy in Figure 1 generalizes examinations
and drugs (e.g., (Exam:Glucose), (Drug:Acetylsalicylic Acid)) as the corre-
sponding higher-level categories (e.g., (Exam:Routine), (Drug:Analgesic)).
{(Drug:Analgesic)} → {(Drug:Omeprazole)} and
{(Drug:Analgesic)} → {(Drug:Pantoprazole)} are examples of generalized
rules. These rules can be used to decide which protective drug recommend
to patients who have been treated with Analgesics for a long time. For ex-
ample, since the latter rule has a higher confidence than the former one (i.e.,
2
3
versus 1
3
), drug Pantoprazole should be recommended first.
A weighted version of the dataset in Table 1 is reported in Table 2. In a
weighted dataset each item has a weight, denoting its relative importance in
the corresponding transaction. For example, the patient with Pid 5 has un-
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Table 3: Example of weighted transactional dataset. Measure: tf-idf of prescriptions
Patient id Examinations and drug prescriptions
1 〈Exam : Glucose, 0〉 〈Drug : Pantoprazole,0.032〉 〈Drug : Acetylsalicylic Acid, 0.7395〉
2 〈Exam : Glucose,0〉 〈Drug : Pantoprazole, 0.065〉 〈Drug : Moxifloxacin, 0.1479〉
3 〈Exam : Glucose, 0〉 〈Drug : Pantoprazole,0.065〉 〈Drug : Acetylsalicylic Acid, 0.3698〉
4 〈Exam : Glucose,0〉 〈Drug : Pantoprazole, 0.097〉 〈Drug : Moxifloxacin, 0.1479〉
5 〈Exam : Glucose,0〉 〈Drug : Omeprazole, 1.165〉 〈Drug : Acetylsalicylic Acid, 0.2958〉
Figure 1: Example of taxonomy built over the transactional patient datasets
dergone Glucose test 2 times and has taken Omeoprazole Acetylsalicylic Acid
5 and 4 times, respectively.
W-GARs, the new type of generalized association rules proposed in this
paper, consider item weights during rule evaluation. To filter out rules
that contain irrelevant information during W-GAR extraction, all general-
ized items in a W-GAR have a minimal relevance score within each transac-
tion. Specifically, itemset occurrences within each weighted transaction are
weighted by the least item weight. For example, W-GAR {(Drug:Analgesic)}
→ {(Drug:Omeprazole)} has weighted support equal to 4, because the least
weighted item in the transaction with Pid 5 has weight 4. Let us consider now
rules {(Drug:Analgesic)} → {(Drug:Omeprazole)} and {(Drug:Analgesic)}
→ {(Drug:Pantoprazole)}. Both rules have the same antecedent but a differ-
ent consequent and they can be used to decide which supplements could be
recommended to patients who are treated with analgesics. It is worth notic-
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ing that, by considering item weights, W-GAR ranking in order of confidence
is reversed with respect to those of traditional rules ( 4
19
with Omeoprazole
versus 3
19
with Pantoprazole). Hence, recommending supplementary drugs
according to the confidence value of traditional rules could be misleading.
2. Weighted patient data analyzer
Weighted Patient Data Analyzer (WeP-DatA) is a new data mining en-
vironment for the advanced analysis of medical data related to the history
of examinations’ and drugs’ prescriptions to patients. WeP-DatA focuses on
supporting physicians and healthcare system managers in discovering inter-
esting and actionable knowledge from large patient data collections.
Currently, the main challenges in effectively coping with real patient data
are: (i) the intrinsic sparseness of the analyzed datasets, which typically con-
tain a very large number of different examinations and drugs and (ii) the
inability of some data mining algorithms (e.g., the generalized association
rule mining algorithms [9, 21, 41]) in coping with data equipped with item
weights. To overcome these issues, WeP-DatA generates a new type of asso-
ciation rule [2], called Weighted Generalized Association Rule (W-GAR).
This section is organized as follows. Section 2.1 thoroughly describes the
context under study, i.e., the analysis of real patient datasets. Section 2.2
discusses the problem of taxonomy generation on top of patient data. Tax-
onomies will be exploited to overcome the limitations of traditional associ-
ation rule mining algorithms in coping with sparse datasets (the issue (i)
mentioned above). Section 2.3 better clarifies the semantics used within this
study for item weight assignment. Finally, Section 2.4 introduces the concept
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of W-GAR and it describes in detail the process of W-GAR mining, which
can be successfully applied to weighted patient data (issue (ii)).
2.1. Context of analysis
Healthcare systems usually collect heterogeneous medical information
into potentially large datasets. To allow physicians to keep track of diag-
nosis and therapies, patient data are commonly stored into separate log files,
which are then integrated into common repositories. For example, physi-
cians commonly record examinations and drugs prescribed to each patient
to analyze the temporal evolution of patients’ state of health and to perform
further analyses. Furthermore, the same information is also deemed worthy
by healthcare system managers in charge of purchasing medical equipments
or planning resource allocations.
Hereafter we will focus our analysis on two main characteristics of patient
data:
• the undergone examinations and
• the prescribed drugs.
To perform data mining analyses, patient data are tailored to a weighted
transactional data format. A weighted patient dataset is a set of weighted
transactions, where each weighted transaction corresponds to a different pa-
tient and it consists of a set of pairs 〈item, weight〉 called weighted items.
Items are related to examinations (e.g., Glucose level) or drugs (e.g., Acetyl-
salicylic Acid) and they are represented in the form (feature:value), where fea-
ture is Examination or Drug while value is the corresponding feature value.
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Weights indicate the item relevance within the corresponding transaction.
The semantics used for assigning item weights in our context of analysis will
be thoroughly discussed in Section 2.3. A more formal definition of weighted
patient dataset is given below.
Definition 2.1. Weighted patient dataset. Let E be the set of all possi-
ble patient examinations, and M the set of all possible drugs. An item ik is a
pair (feature,vq), where vq ∈ E if feature is equal to Examination or vq ∈ M
if feature is equal to Drug. A weighted item is a pair 〈ik, wk〉, where wk is a
real number denoting item relevance. A weighted patient dataset D is a set
of weighted transactions, where each weighted transaction tj ∈ D is a set of
weighted items {〈ijk, w
j
k〉}.
For instance, Table 2 reports an example of weighted patient dataset.
For each patient examinations and drugs are weighted by the corresponding
number of prescriptions (e.g., the patient with Pid 5 has taken Omeoprazole 5
times, while drug Acetylsalicylic Acid was prescribed 10 times to the patient
with Pid 1). According to Definition 2.1, weighted item 〈Exam : Glucose, 6〉,
which occurs in the transaction with Pid 1, indicates that the corresponding
patient has undergone the glucose level test 6 times.
2.2. Taxonomy generation
Real-world data are intrinsically sparse. For example, patient data often
contain hundreds of examinations and thousands of drugs. Hence, the anal-
ysis of the raw data could be challenging because most relevant information
can remain undisclosed at first glance.
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Analyzing data at different abstraction levels allows experts to discover
interesting and actionable knowledge which may remain hidden at the lowest
granularity level. This approach is commonly used in data warehousing and
data mining analyses. For example, OLAP analyses commonly exploit hi-
erarchies built over the schema dimensions to perform aggregation and drill
down operations over historical data [27].
We target the discovery of associations among patient data items at dif-
ferent arbitrary levels by means of generalized association rule discovery [41].
To our purpose, data are equipped with analyst-provided taxonomies. Tax-
onomies built over weighted patient data aggregate examinations and drugs
into high-level concepts, i.e., examinations are generalized as examination
categories and drugs as drug categories. A more formal definition follows.
Definition 2.2. Taxonomy. Let D be a weighted patient dataset and I the
set of items in D (disregarding the corresponding weights). A generalization
hierarchy GHIk (Ik ⊆ I) built over D is a hierarchy of aggregations defined
over a subset of items in I, where hierarchy leaves are items in I, while
non-leaf nodes in GHIk are ancestors of their corresponding children. Each
hierarchy has a root node (denoted as ⊥) which aggregates all its items. A
taxonomy T built over D consists of a set of generalization hierarchies GHIk
for which ∪GHIk∈T Ik = I.
Although taxonomies can potentially contain many generalizations over
the same item (e.g., many categories for the same examination), for the sake
of simplicity hereafter we will consider only taxonomies containing at most
one generalization per item.
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Given a taxonomy T built over a weighted patient dataset D, a weighted
generalized item is a pair 〈gik, Wk〉, where gi is a non-leaf node in T (also
called generalized item), while Wk is its corresponding weight. To mine rules
at different abstraction levels in a single extraction, generalized rule mining
algorithms handle both generalized and non-generalized items.
An example of taxonomy built over the running example dataset is re-
ported in Figure 1. Examinations Blood count and Glucose level are classified
as Routine, whereas drugs Pantoprazole and Omeoprazole are generalized as
Protection. Finally, drugs Acetylsalicylic Acid andMoxifloxacin are classified
as Analgesic and Antibiotic, respectively. (Drug :Analgesic) is an example of
generalized item, while 〈Drug :Analgesic, 5〉 is an example of weighted gen-
eralized item, which indicates that the weight of item (Drug :Analgesic) is
5.
To define aggregations over examinations and drugs, analysts could ex-
ploit standard classification systems, e.g., for drugs the ATC classification
system available at [7]. Even though our data model currently considers
only examinations and drugs, it can be easily extended by inserting data re-
lated to additional patient features (e.g., social status, job, phenotype) and
the corresponding high-level categories.
2.3. Weight semantics
Since real-life data analyses are commonly targeted to multiple data facets
and measures, item weights in different datasets could potentially represent
different information. We focus our empirical studies on two representative
measures tailored to patient data analysis:
A) the number of the drug and examination prescriptions and
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B) the tf-idf of the drug and examination prescriptions.
A more detailed description of each measure is given below.
Measure (A): number of prescriptions. Given a weighted transaction
tj ∈ D, the weight w
j
k of weighted item 〈i
j
k, w
j
k〉 indicates the number of
prescriptions of the examination/drug associated with ik to the patient cor-
responding to transaction tj .
Table 2 reports an example of weighted patient dataset in which weights
are defined according to measure (A). For example, since patient with Pid
5 has taken Omeoprazole 5 times, item (Drug:Omeprazole) has weight 5.
The use of this measure allows us to figure out interesting and hidden recur-
rences in the history of drug and examination prescriptions. For instance,
such information is worth considering by healthcare system managers to ef-
ficiently set up and manage disease prevention protocols or to plan resource
allocations.
Since generalized items represent either drug categories or examination
categories, we are interested in analyzing the cumulative number of pre-
scriptions per category and patient. Hence, given a weighted transaction
tj ∈ D, the weight W
j
k of weighted generalized item 〈gi
j
k, W
j
k 〉 is the number
of prescriptions for the patient corresponding to tj of the examinations/drugs
belonging to the category represented by generalized item gi.
For example, according to the dataset in Table 2 and the taxonomy in
Figure 1, the weight associated with generalized item (Examination:Routine)
in the transaction with Pid 1 is 6, because the transaction contains just one
of its descendant items, i.e., (Examination:Glucose examination), and its
corresponding weight is 6.
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Measure (B): tf-idf of prescriptions. Given a weighted transaction
tj ∈ D, the weight w
j
k of weighted item 〈i
j
k, w
j
k〉 expresses the term frequency-
inverse document frequency (tf-idf) statistics related to the examination/-
drug associated with ik and to the patient corresponding to transaction tj .
The term frequency-inverse document frequency (tf-idf) index is an es-
tablished statistic frequently used to analyze textual documents. In our con-
text, each patient is equivalent to a document and each examination/drug is
equivalent to a word.
Table 3 reports an example of weighted patient dataset in which weights
are defined according to measure (B).
The use of this measure is aimed at discovering combinations of exami-
nations/drugs that have frequently been prescribed together to few patients.
Such patterns are worth considering to highlight peculiar prescriptions re-
lated to specific patient clusters, e.g., patients with specific diseases or pro-
files.
The tf-idf evaluator [32] is usually expressed in matrix form [45]. Let TI
be the tf-idf matrix for weighted patient dataset D, where each row represents
a distinct patient (i.e., a distinct weighted transaction), while each column
corresponds to a distinct examination or drug (i.e., an item). Each element
tijk of the tf-idf matrix TI combines the frequency of the k-th item in the
j-th transaction with the inverse of the logarithm of its transaction frequency
in D. The tf-idf matrix value tijk can be expressed as follows:
tijk =
njk
|tj |
· log
|D|
|{tj ∈ D : ik ∈ tj}|
(1)
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where njk is the number of prescriptions of the examination/drug correspond-
ing to the k-th item ik for the patient associated with transaction tj , D is the
weighted patient dataset, |tj | is the number of items that are contained in the
j-th transaction tj , and
|D|
|{tj∈D : ik∈tj}|
represents the logarithm of the inverse
of the fraction of transactions in which item ik occurs in the whole dataset,
i.e., the inverse of the frequency of patients to whom the drug/examination
corresponding to ik has been prescribed at least once.
The logarithm is minimal when the inverse transaction frequency is equal
to 1 (i.e., when a drug/examination has been prescribed to all patients in
the datasets). In such a case, the corresponding td-idf value reduces to zero.
For example, item (Exam:Glucose) has tf-idf weight equal to zero in Table 3
because the exam has been prescribed at least once to all patients and thus
the idf component of the tf-idf statistics is reduced to zero. Conversely, a
high tf-idf value indicates that the specific examination/drug has frequently
been prescribed to few patients. For example, item (Exam:Omeoprazole)
has the highest tf-idf value in Table 3 (1.165) because it has been prescribed
many times (5) to only one out of five patients in the dataset.
2.4. Generalized weighted association rule mining
We focus on discovering a new type of association rule, i.e., the Weighted
Generalized Association Rule (W-GAR), from weighted patient datasets equipped
with taxonomies (see Definitions 2.1 and 2.2, respectively).
This section is organized as follows. Section 2.4.1 introduces preliminary
concepts related to the traditional (unweighted) generalized association rule
mining problem, while Section 2.4.2 formally introduces the concept of W-
GAR and it thoroughly describes the W-GAR mining task addressed by this
15
paper.
2.4.1. Generalized association rules
Generalized association rule mining [41] is a widely exploratory data min-
ing technique to discover hidden and multiple-level correlations among large
datasets equipped with (analyst-provided) taxonomies. A generalized as-
sociation rule is an implication A → B, where A and B are disjoint sets
of generalized or not generalized items, also called generalized k-itemsets. A
(generalized) k-itemset is set of (generalized) items of size k. In the following
A and B will be also denoted as antecedent and consequent, respectively.
In our context of analysis, generalized itemsets are arbitrary sets of ex-
aminations, drugs, examination categories, or drug categories. Generalized
rules express implications between examinations or drugs, possibly at differ-
ent abstraction levels. Generalized rules that contain only examinations or
drugs, i.e., items at the lowest granularity level, will be denoted hereafter
as low-level rules, rules containing only examination/drug categories will be
denoted as high-level rule. Finally, rules that contain a mixture of gener-
alized and not generalized items will be denoted as cross-level rules. For
example, let us consider again the dataset in Table 1 and the taxonomy in
Figure 1. {(Exam:Cardiovascular)} → {(Exam:Glucose)} is an example of
cross-level generalized rule which indicates that cardiovascular examinations
are frequently prescribed in conjunction with a specific routine examination,
i.e., the glucose level test.
Since generating all the possible itemsets and rules is computationally
intractable [2] and it would require experts to deal with a very large set
of (potentially redundant) patterns, generalized association rule extraction
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typically entails the following two steps [41]:
• Frequent generalized itemset mining, which addresses the extraction
of all generalized itemsets that frequently occur in D, i.e., generalized
itemsets whose support value is above a given threshold minsup and
• Strong generalized association rule extraction, which entails generating,
from the subset of previously mined itemsets, all generalized rules that
frequently occur and that hold in most cases in D, i.e., generalized
rules whose support value is above a given threshold minsup and whose
confidence value is above a given threshold minconf .
The support of a generalized itemset indicates its observed frequency of
occurrence in the source dataset. If an item is generalized, its occurrence in
a transaction is counted if and only if any of its descendant item (according
to the input taxonomy) occurs.
For example, the generalized 2-itemset {(Exam:Routine), (Drug:Omeprazole)}
has (absolute) support value equal to 1 in Table 1, because it occurs only in
the transaction with Pid 5 (the occurrence of exam category Routine is due
to those of exam Glucose).
Hereafter we formally introduce the two main generalized association rule
quality indexes, i.e., support and confidence [45].
Definition 2.3. Generalized rule support and confidence. Let D be an
(unweighted) patient dataset and A → B an arbitrary generalized association
rule. Let sup(A) and sup(B) be support of A and B in D, respectively.
• The support of A → B, denoted as sup(A → B), is defined as the
support of generalized itemset A ∪B in D.
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• The confidence of A → B, denoted as conf(A → B) is defined as
the conditional probability of occurrence of B given the A in D, i.e.,
conf(A→ B)= sup(A∪B)
sup(A)
.
Note that, based on the above definitions, item occurrences in each dataset
transaction are treated equally, even if items are not equally relevant within
each transaction.
For example, rule {(Drug:Analgesic)} → {(Drug:Omeprazole)} has sup-
port equal to 1 in Table 1, because it covers only the transaction with Pid
5. Its confidence value is 1
3
, because only one third of the patients in the
dataset who took Analgesic drugs have also taken Omeoprazole.
To extract generalized association rules from transactional datasets many
algorithms have already been proposed in literature (e.g., [9, 21, 41]). Un-
fortunately, to the best of our knowledge, none of them is able to cope with
weighted data. In the next section, we overcome this issue by presenting a
new type of generalized rule, i.e., the weighted generalized association rule.
2.4.2. Weighted generalized association rules
We present a new type of association rule that allows us to overcome
both the following issues at the same time: (i) the sparseness of real-life data
and (ii) the inability of state-of-the-art generalized rule mining to cope with
weighted data. On the one hand, state-of-the-art association rule mining
approaches tailored to weighted data (e.g., [49, 44]) are unable to effectively
deal with sparse data, because they discover only associations among data
items at the lowest granularity level. On the other hand, generalized asso-
ciation rule mining strategies (e.g., [9, 21, 41]) are currently unable to cope
18
with weighted data.
Weighted Generalized Association Rules (W-GARs) are generalized rules
A → B extracted from transactional datasets equipped with item weights.
In our context of analysis, we extract generalized rules from weighted patient
datasets by considering not only the simple item occurrences in the source
dataset but even the weights associated with data items within each trans-
action. Specifically, to evaluate generalized rule quality indexes, item occur-
rences within each transaction are weighted by the corresponding weights.
To our purpose, we preliminary extend the definition of generalized item-
set support to the case of weighted data. We will denote such a measure
as w-support [17]. The w-support of a generalized itemset is the sum of the
weight of its least weighted item in the itemset for each transaction in which
the itemset occurs.
Definition 2.4. Itemset w-support. Let D be an weighted patient dataset
and I an arbitrary generalized itemset. Let W(I, tj) be the matching weight
of a generalized itemset I with respect to trj, which is defined as follows:
W(I, tj) =


mink | ik∈I w
j
k if all items ik in I occur in tj ,
0 otherwise
The w-support of I in D is the summation of all matching weights of I for
every transaction in D:
w-sup(I) =
∑
tj∈D
W(I, tj)
For example, the support of {(Exam:Routine), (Drug:Omeprazole)} in
Table 2 is 2 because the itemset occurs only in the transaction with Pid 5
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and the least weighted item between (Exam:Routine) and (Drug:Omeprazole)
has weight equal to 2.
The concepts of support and confidence of a traditional generalized rule
(see Definition 2.3) are extended to W-GARs below. We will denote by
w-support and w-confidence the respective W-GAR quality measures.
Definition 2.5. W-GAR w-support and w-confidence. Let D be a
weighted patient dataset and A → B a W-GAR. Let w-sup(A) and w-sup(B)
be the w-support of A and B in D, respectively.
• The w-support of A→ B, denoted as w-sup(A→ B), is defined as the
w-support of generalized itemset A ∪ B in D.
• The w-confidence of A → B, denoted as w-conf(A→ B) is defined as
the weighted conditional probability of occurrence of B given the A in
D i.e. w-conf(A→ B)=w-sup(A∪B)
w-sup(A)
For example, W-GAR {(Exam:Routine)} → {(Drug:Omeprazole)} has w-
support equal to 2 and w-confidence equal to 2
20
=10% because the w-support
of the rule antecedent ({(Exam:Routine)}) is 20. Note that disregarding
item weights the same rule would have a confidence equal to 20%. The gap
between the two values is due to the fact that the transaction in which the rule
actually occurs (Pid 5) has a relatively low matching weight (2) compared
to the others. Hence, the weighted conditional probability of occurrence of
(Drug:Omeprazole) given (Exam:Routine) is lower than the unweighted one.
To discover interesting and actionable multiple-level associations among
weighted patient data, we discover and select a worthwhile subset of W-
GARs, denoted as strong WARs, from the analyzed data.
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Definition 2.6. Strong W-GAR. Strong W-GARs are W-GARs whose
• w-support in D is above a given threshold minwsup
• w-confidence in D, is above a given threshold minwconf
In Section 3 the strong W-GARs mined from a real weighted patient
dataset were validated and some worthy examples of application of the dis-
covered patterns are presented.
To extract strong W-GARs, we adopted the usual two-step process [3],
i.e., frequent itemset mining followed by strong association rule extraction.
To mine generalized frequent itemsets from weighted data, we adapted the
FP-Growth-like [22] weighted itemset mining algorithm implementation, which
was first proposed in [17], to generalized itemset mining. Since the algorithm
proposed in [17] was designed to mine non-generalized itemsets, we followed
the approach previously adopted in [10] to integrate taxonomy information.
Specifically, we first extended each dataset transaction by appending the cor-
responding item generalizations. Then we mined frequent generalized item-
sets while preventing the generation of invalid candidate itemsets, i.e., those
generalized itemsets that contain both an item and any of its generalizations.
To perform W-GAR mining on top of frequent itemsets, we used our
slightly modified implementation of the rule mining step of the Apriori algo-
rithm [3].
2.4.3. Algorithm complexity
The complexity of the W-GAR algorithm is comparable to those of tradi-
tional Apriori-based [3] association rule mining algorithms. More specifically,
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it is linear in the number of transactions, i.e., O(n), where n is the number
of transactions, while it is combinatorial in the number of average items per
transaction. The complexity of the rule extraction process is mainly due
to the generalized itemset mining step and it mainly depends on the an-
alyzed data distribution. Enforcing a minimum support threshold reduces
the number of generated item combinations thus making the mining problem
tractable on real data. If no support threshold is enforced during the mining
process, the complexity of the process of itemset generation is O(d · 2d−1),
where d is the number of distinct items in the source data [46]. A thorough
analysis of the impact of the support threshold on the characteristics of the
mining result is given in Section 3.3.
3. Experimental results
To assess the effectiveness and efficiency of the proposed approach we
performed a set of experiments on a real dataset gathered by an Italian
Health Center.
This section is organized as follows. Section 3.1 describes the charac-
teristics of the analyzed dataset and the semantics used for assigning item
weights. Section 3.2 summarizes the most relevant results and it highlights
the significance and usability of the rules discovered with different weighting
measures. A comparison between traditional and weighted generalized rules
is also reported. Section 3.4 compares the rules extracted by our approach
with those mined by a different weighted association rule mining approach.
Finally, Section 3.5 evaluates the efficiency of our approach in terms of exe-
cution time.
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Table 4: Generalization hierarchy over examinations
Examination category Examination
Checkup visit
Glucose level
Routine examinations Urine test
Venous blood
Complete blood count
Hemoglobin
Electrocardiogram
Cardiovascular examinations Cholesterol
HDL Cholesterol
Triglycerides
Fundus oculi
Eye examinations Angioscopy
Complete eye examination
Retinal photocoagulation
AST
Liver examinations ALT
Bilirubin
Gamma GT
Urin acid
Microscopic urine analysis
Kidney examinations Culture urine
Creatinine clearance
Creatinine
Microalbuminuria
Carotid examinations ECO Doppler carotid
Limb examinations ECO Doppler limb
All the experiments were performed on a quad-core 3.30 GHz Intel Xeon
workstation with 16 GB of RAM, running Ubuntu Linux 12.04 LTS.
3.1. Dataset and taxonomy
To evaluate the effectiveness of the proposed approach we analyzed a real
dataset collecting the drugs and examinations prescribed to the overt pa-
tients with diabetes of an Italian Health Center. The dataset, collected in
year 2007, consists of 648,797 records, where each record corresponds to a
set of daily examination/drug prescriptions to a given patient. Clearly, each
examination/drug can be prescribed several times to the same patient or to
different patients. The number of patients under analysis is 8,749. We used
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two different weighting measures to evaluate examination/drug importance,
i.e., simple frequency and tf-idf of the prescription. To this purpose, we gen-
erated one distinct dataset version per measure. Hereafter we will denote
the two dataset versions as Diabetes-Freq and Diabetes-tf-idf, respectively.
Each dataset contains a set of weighted transactions, one for each patient.
Transactions consist of a set of examinations and/or drugs which were pre-
scribed at least once to the corresponding patient. To each examination/drug
a weight is assigned by using the appropriate measure, i.e., the number of
prescriptions in Diabetes-Freq or the tf-idf measure in Diabetes-tf-idf.
To enable generalized rule mining we exploited two hierarchies built over
examinations and drugs, respectively. Table 4 reports the generalization
hierarchy defined on the set of examinations under analysis. It contains
26 examinations clustered into 7 examination categories. The examination
categories were selected based on the expert-driven classification reported
in [5].
To generate a hierarchy over drugs, we exploited the levels of the ATC
classification system defined in [7]. Each level represents a different abstrac-
tion level of aggregation on the set of considered drugs. More specifically,
the fifth level of the code indicates the chemical substance (i.e., the drug),
while the chemical subgroup is encoded by the fourth level. The third level
indicates the therapeutic/pharmacological subgroup and the second level rep-
resents the therapeutic main group of the drug. Finally, the first level of the
code indicates the anatomical main group, also called main category in the
following. In our experiments we used a generalization hierarchy over drugs
whose leaves are the drugs encoded using the fifth level of the ATC classi-
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fication system defined in [7]. Drugs are aggregated according to the ATC
classification into the upper-level categories. For example, drug B01AC06
(i.e., acetylsalicylic Acid) is a leaf node of the generalization hierarchy and
its is generalized as the B01AC group (i.e., platelet aggregation inhibitors
excluding heparin). The platelet aggregation inhibitors excluding heparin is
then generalized as the B01 group (i.e., Antithrombotic agents), which, in
turn, is further aggregated into the main category B (i.e., Category Blood
and blood forming organs). Table 5 reports some examples of first- and
fifth-level elements of the ATC classification.
3.2. Evaluation of the mined rules
We performed several experiments on the analyzed data to identify most
interesting rules. Section 3.2.1 analyzes theW-GARs mined from the Diabetes-
Freq dataset, while Section 3.2.2 presents the most interesting W-GARs
mined from Diabetes-tf-idf.
In our analyses we separately considered the rules containing examina-
tions and drugs. Furthermore, since drug and examination weights are, in
general, not directly comparable we disregarded the W-GARs containing a
mixture of drugs and examinations. However, the proposed methodology is
general and it can potentially handle item weights with different semantics
provided that a compound weighting scheme is used.
To select a manageable subset of potentially interesting strong W-GARs
we tested several values of w-support and w-confidence thresholds. Further-
more, to validate rule interestingness we also considered two entropy-based
evaluators, i.e., AntInt and ConsInt [35]. Entropy-based evaluators have
largely been used to pinpoint most reliable correlations from data items [46].
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Table 5: Portion of the generalization hierarchy over drugs
Drug category Drug
(1st ATC level) (5th ATC level)
A01AA01: Sodium fluoride
Category A: Alimentary tract and metabolism A05AX01: Piprozolin
. . .
B01AC06: Acetylsalicylic Acid
Category B: Blood and blood forming organs B03AA03: Ferrous gluconate
. . .
C09AA05: Ramipril
Category C: Cardiovascular system C10AA07: Rosuvastatin
. . .
D01AA02: Natamycin
Category D: Dermatologicals D01AA03: Hachimycin
. . .
G04CB01: Finasteride
Category G: Genito-urinary system and G04CX03: Mepartricin
sex hormones . . .
H02AA02: Fludrocortisone
Category H: Systemic hormonal preparations, H02AB07: Prednisone
excluding sex hormones and insulins . . .
J01MA12: Levofloxacin
Category J: Antiinfectives for systemic use J02AC04: Posaconazole
. . .
L01AA07: Trofosfamide
Category L: Antineoplastic and L01AB01: Busulfan
immunomodulating agents . . .
M03AC10: Mivacurium chloride
Category M: Musculo-skeletal system M03BA05: Febarbamate
. . .
N04AA02: Biperiden
Category N: Nervous system N04AB01 Etanautine
. . .
P01AA04: Chlorquinaldol
Category P: Antiparasitic products, P01AC01: Diloxanide
insecticides and repellents . . .
R03AC02: Salbutamol
Category R: Respiratory system R03BA02: Budesonide
. . .
S02AA10: Acetic Acid
Category S: Sensory organs S02BA03: Prednisolone
. . .
V10XX01: Sodium phosphate
Category V: Various V10XA01: Sodium iodide
. . .
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The achieved results, summarized in the following sections, show that the
most appropriate minimum support threshold value to set depends on the
analyzed data distribution. Furthermore, it appears that setting relatively
high minimum confidence threshold values may result in pruning highly cor-
related and potentially actionable rules. Therefore, we identified the most
appropriate support threshold value to set by comparing the results of mul-
tiple extractions on each dataset with different configuration settings and we
deemed low-confidence rules to be worth considering during manual inspec-
tion as well as high-confidence ones.
3.2.1. Analysis of the number of prescriptions
We considered the frequency of drug/examination prescriptions because
we deemed it as a significant indicator to support physicians in the following
analyses: (i) select the most appropriate treatments, (ii) check the adherence
of prescriptions to standard guidelines, and (iii) plan healthcare resource
allocations.
To perform our analyses, we first differentiated between low-, cross-, and
high-level W-GARs according to the definition reported in Section 2.4. This
preliminary rule classification allows us to categorize the rule content based
on its corresponding abstraction level in the input taxonomy.
The trend of variation of w-confidence values of low-, cross-, and high- W-
GARs is pretty similar to those of traditional rule confidence values (i.e., the
confidence of traditional generalized rules mined disregarding item weights).
On average, W-GAR w-confidence appears to be lower than traditional con-
fidence for cross- and high-level rules because generalized item occurrences
are weighted by the actual descendant item weight within each transaction
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and thus in w-support counting all descendant item occurrences are no longer
weighted equally as in traditional support counting.
Notably, rule ranking in order of confidence often changes from tradi-
tional rules to W-GARs. More specifically, some of top-ranked traditional
rules were downgraded because embedding item weight information the tra-
ditional confidence value decreases significantly. This result demonstrates
that considering only examination/drug co-occurrences rather than their rel-
evance weight is a suboptimal choice, which could yield rather different and
potentially unreliable results. Consequently, W-GARs are more suitable than
traditional generalized rules for effectively addressing analyses such as the
ones mentioned above.
Weighted generalized rules related to examinations. Table 6 reports a repre-
sentative subset of W-GARs mined from Diabetes-Freq and containing only
examinations. The experiments were performed by setting minsup to 5001
and minconf to 0. Table 7 reports the corresponding (unweighted) rules
mined from the unweighted version of the diabetes dataset. Below we report
a detailed comparison between a worthwhile subset of low-, cross-, and high-
level W-GARs and the corresponding traditional rules. Although, for the
sake of simplicity, in the following sections we mainly focus on 2-length rules
(i.e., rules whose antecedent and consequent are singletons), our approach
can extract rules of arbitrary length.
Analysis of cross-level rules. The cross-level W-GARs in Table 6 rep-
resent the association between the examinations in the Liver category and
1When not otherwise specified, we consider absolute minimum support thresholds
throughout the paper.
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Table 6: Examples of W-GARs related to examinations. Weighting measure: simple
frequency of prescriptions
ID Rule W-sup W-conf AntInt ConsInt
Cross-level rules
1 {(Exam:Liver)} → {(Exam:Creatinine)} 8395 30% 0.83 0.66
2 {(Exam:Liver)} → {(Exam:Uric Acid)} 7215 25% 0.73 0.66
3 {(Exam:Liver)} → {(Exam:Microscopic urine analysis)} 7107 25% 0.84 0.68
4 {(Exam:Liver)} → {(Exam:Culture urine)} 5426 19% 0.83 0.72
5 {(Exam:Liver)} → {(Exam:Creatinine clearance)} 4078 14% 0.87 0.81
6 {(Exam:Liver)} → {(Exam:Microalbuminuria)} 3633 13% 0.91 0.81
High-level rules
7 {(Exam:Liver)} → {(Exam:Kidney)} 23953 84% 0.60 0.45
8 {(Exam:Kidney)} → {(Exam:Cardiovascular)} 28777 75% 0.75 0.43
9 {(Exam:Eye)} → {(Exam:Cardiovascular)} 6298 85% 0.96 0.43
10 {(Exam:Cardiovascular)} → {(Exam:Eye)} 6298 17% 0.96 0.70
11 {(Exam:Liver), (Exam:Cardiovascular)} → {(Exam:Kidney)} 20562 92% 0.67 0.45
Low-level rules
12 {(Exam:Creatinine clearance)} → {(Exam:HDL Cholesterol)} 3760 89% 0.84 0.54
13 {(Exam:Microalbuminuria)} → {(Exam:HDL Cholesterol)} 3425 88% 0.89 0.54
14 {(Exam:Urin acid)} → {(Exam:HDL Cholesterol)} 6300 84% 0.79 0.54
15 {(Exam:Microscopic urine analysis)} → {(Exam:HDL Cholesterol)} 5848 74% 0.85 0.54
16 {(Exam:Creatinine)} → {(Exam:HDL Cholesterol)} 5937 65% 0.89 0.54
one specific examination belonging to the Kidney category. Among them,
R1 : {(Exam : Liver)} → {(Exam : Creatinine)} is the W-GAR with
top confidence value (30%) and it is characterized by relatively high an-
tecedent and consequent interest values (83% and 66%, respectively). Note
that while entropy-based evaluators evaluate the correlation between data
items regardless of their corresponding weights, the w-confidence value de-
pends on the weights of the items in the rules. Rule R1 indicates that the
patients who performed 10 (100) examinations belonging to the liver category
usually repeat the creatinine examination 3 (30) times. If we consider the
corresponding traditional rule (see Table 7), R1 appears to be the rule with
lowest confidence value (39%). According to traditional rule definition, R1
implies that most patients who performed at least one examination belonging
29
Table 7: Examples of traditional unweighted generalized rules related to examinations
ID Rule Sup Conf AntInt ConsInt
Cross-level rules
1 {(Exam:Liver)} → {(Exam:Creatinine)} 1111 39% 0.83 0.66
2 {(Exam:Liver)} → {(Exam:Uric Acid)} 2135 75% 0.73 0.66
3 {(Exam:Liver)} → {(Exam:Microscopic urine analysis)} 1899 66% 0.84 0.68
4 {(Exam:Liver)} → {(Exam:Culture urine)} 1890 66% 0.83 0.72
5 {(Exam:Liver)} → {(Exam:Creatinine clearance)} 1444 51% 0.87 0.81
6 {(Exam:Liver)} → {(Exam:Microalbuminuria)} 1146 40% 0.91 0.81
High-level rules
7 {(Exam:Liver)} → {(Exam:Kidney)} 2695 94% 0.60 0.45
8 {(Exam:Kidney)} → {(Exam:Cardiovascular)} 2948 90% 0.75 0.43
9 {(Exam:Eye)} → {(Exam:Cardiovascular)} 2275 72% 0.96 0.43
10 {(Exam:Cardiovascular)} → {(Exam:Eye)} 2275 55% 0.96 0.70
11 {(Exam:Liver), (Exam:Cardiovascular)} → {(Exam:Kidney)} 2563 95% 0.67 0.45
Low-level rules
12 {(Exam:Creatinine clearance)} → {(Exam:HDL Cholesterol)} 1400 93% 0.84 0.54
13 {(Exam:Microalbuminuria)} → {(Exam:HDL Cholesterol)} 1137 90% 0.89 0.54
14 {(Exam:Microscopic urine analysis)} → {(Exam:HDL Cholesterol)} 1925 87% 0.85 0.54
15 {(Exam:Creatinine)} → {(Exam:HDL Cholesterol)} 1050 84% 0.89 0.54
16 {(Exam:Urin acid)} → {(Exam:HDL Cholesterol)} 2100 93% 0.79 0.54
the Liver category have undergone the creatinine examination at least once.
Such information is definitely less precise and thus potentially misleading for
non-expert users. For example, physicians who have to allocate resources for
medical examinations could make wrong decisions unless considering the ac-
tual number of examination prescriptions per patient. W-GAR w-confidence
actually depends also on the expected frequency of exam repetitions. For
example, according to the guidelines [25] the main Liver examinations are
recommended to be prescribed three times a year to diabetics, whereas Cre-
atinine level examination just once a year. Hence, W-GAR R1 confirms the
adherence of doctor’s prescriptions to guidelines.
The first six W-GARs in Tables 6 summarize the most frequently pre-
scribed kidney examinations prescribed to patients who have already under-
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gone liver examinations. Such information is worth considering for verifying
treatment adherence to standard guidelines as well as to support physicians
in making future decisions. All these rules have relatively high antecedent
and consequent interest values (AntInt ≥ 73%, ConsInt ≥ 66%). However,
from the comparison between the W-GARs in Tables 6 and the rules in
Table 7 a different confidence ranking appears. Therefore, weighting exam
occurrences by the number of prescriptions really matters in deciding which
guidelines are mostly disobeyed.
Analysis of high-level rules. Let us consider the following two tradi-
tional rules: R10 : {(Exam : Cardiovascular)} → {(Exam : Eye)} and
R9 : {(Exam : Eye)} → {(Exam : Cardiovascular)} (Table 7). When com-
paring them with the corresponding W-GARs (Table 6), it appears that the
R10’s confidence value significantly decreases (17% vs 55%) whereas the R9’s
confidence value slightly increases (85% vs 72%). Both rules R9 and R10 con-
sist of strongly correlated items (AntInt=96%, ConsInt=96%). W-GAR R10
implies that patients who performed 10 (100) cardiovascular examinations on
average perform 1.7 (17) examinations belonging the Eye category as well.
Hence, the correlation between cardiovascular and eye examinations seems
to be weak. On the other hand, W-GAR R9 highlights a strong correla-
tion between eye and cardiovascular examinations. Specifically, it indicates
that, on average, patients who have undergone 10 (100) eye examinations
have also performed 8.5 (85) cardiovascular examinations. Since guidelines
for diabetes treatments [25] recommend to repeat cardiovascular and eye ex-
aminations at least once a year, it implies that a relatively large number of
patients (15%) did not adhere to guidelines, i.e., they have repeated eye tests
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but not cardiovascular tests.
Note that, in the analyzed scenario, if we enforce relatively high confi-
dence thresholds (e.g., minconf=70%) many interesting low-confidence rules
(e.g., R10 in Table 6) would be discarded thus potentially actionable infor-
mation would be lost. Hence, to evaluate the adherence of examination pre-
scriptions to guidelines low-confidence rules are deemed to be as interesting
as high-confidence ones. Therefore experts are recommended to set averagely
low confidence thresholds. In case the number of mined rules becomes too
large for manual inspection, rules may be ranked by decreasing AntInt/Con-
sInt values and only the top ranked rules can be manually explored.
Analysis of low-level rules. Let us consider the high-level rule
R8 : {(Exam : Kidney)} → {(Exam : Cardiovascular)} first (see Table 6).
It indicates that patients who have undergone any examination belonging
the Kidney category are very likely to undergo cardiovascular examinations
as well (75% of likelihood). Low-level rules allow us to deepen into the
analysis of such a pattern. For example, we can consider the rules that
contain the HDL cholesterol examination in the rule consequent to figure out
the Kidney examinations that are likely to be prescribed in conjunction with
the HDL cholesterol test. Traditional rule R16 : {(Exam : Urin acid)} →
{(Exam : HDL cholesterol)} has the top confidence value (93%), but it
appears to be misleading, because the corresponding W-GAR has a relatively
low confidence compared to other similar W-GARs (63%). Conversely, rule
R12: {(Exam : Creatinine clearance)} → {(Exam : HDL colesterol)}
and its corresponding W-GAR have both high (w-)confidence (respectively
93% and 89%) and thus they can be used to analyze the correlation between
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Table 8: Examples of W-GARs related to drugs. Weighting measure: simple frequency of
prescriptions.
ID Rule W-sup W-conf AntInt ConsInt
Cross-level rules
1 {(Drug:Category B)} → {(Drug:B01AC06 )} 8373 59% 0.51 0.82
2 {(Drug:Category B)} → {(Drug:B01AC05 )} 2058 15% 0.92 0.97
3 {(Drug:Category B)} → {(Drug:B01AB06 )} 1384 10% 0.88 0.95
4 {(Drug:Category B)} → {(Drug:B01AA03 )} 741 5% 0.96 0.98
High-level rules
5 {(Drug:Category B)} → {(Drug:Category C )} 12922 91% 0.96 0.42
B = Blood and blood forming organs
C = Cardiovascular system
6 {(Drug:Category C )} → {(Drug:Category B)} 12922 17% 0.96 0.72
Table 9: Examples of traditional unweighted generalized rules related to drugs
ID Rule Sup Conf AntInt ConsInt
Cross-level rules
1 {(Drug:Category B)} → {(Drug:B01AC06 )} 1670 71% 0.51 0.82
2 {(Drug:Category B)} → {(Drug:B01AC05 )} 323 14% 0.92 0.97
3 {(Drug:Category B)} → {(Drug:B01AB06 )} 485 21% 0.88 0.95
4 {(Drug:Category B)} → {(Drug:B01AA03 )} 54 3% 0.96 0.98
High-level rules
5 {(Drug:Category B)} → {(Drug:Category C )} 2101 90% 0.96 0.42
B = Blood and blood forming organs
C = Cardiovascular system
6 {(Drug:Category C )} → {(Drug:Category B)} 2101 50% 0.96 0.72
the HDL cholesterol test and other examinations. More in detail, based
on the W-GAR rule, patients who repeated 10 (100) Creatinine Clearance
examination are likely to repeat HDL cholesterol examination approximately
9 (89) times.
Summarizing, we observed that, in many cases, estimates made using
W-GARs appear to be more consistent and realistic than those made using
traditional generalized rules.
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Weighted generalized rules related to drugs. We performed a second round
of experiments by considering drugs instead of examinations. For this ex-
perimental session, we used again the simple frequency of prescription as
weighting measure and we set minsup to 500 and minconf to 0. Even in
this case we selected a subset of potentially interesting patterns, which are
reported in Table 8. These patterns can be exploited by healthcare system
managers to profile drug prescriptions and thus to verify prescription adher-
ence to guidelines or to plan drug provision. We compared again traditional
generalized rules (see Table 9) with W-GARs (see Table 8).
The obtained results are similar to those achieved with examinations.
Specifically, W-GAR and traditional rule ranking in order of confidence rel-
evantly change. For example, let us consider the four cross-level W-GARs in
the form {(Drug:Category B)} → {(Drug:Specific drug of category B)} re-
ported in Table 8. They can be used to plan Category B drug provision. For
example, drug B01AC06 (acetylsalicylic Acid) appears to be the most pre-
scribed drug among those belonging to Category B. More specifically, 59% of
the prescriptions of Category B drugs are B01AC06 prescriptions, whereas
only 15%, 10%, and 5% of the Category B’s prescriptions are related to
drugs B01AC05, B01AB06, and B01AA03, respectively. These results can
be deemed worthy by the National Health Center to plan drug provision. Let
us now consider the four corresponding traditional rules in Table 9. The con-
fidence value of a rule in the form {(Drug:Category B)} → {(Drug:Specific
drug of category B)} represents the percentage of patients to whom a specific
Category B drug has been prescribed at least once with respect to the total
number of patients who have taken a Category B drug at least once. Based
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on traditional rule confidence, we could make only rough estimates and thus
a wrong drug provision could be planned. For example, the ranking of Cate-
gory B drugs is misleading, because B01AB06 appears to be more frequently
prescribed than B01AC05, even if this is not case. Note that most of the
rules in Table 8 related to Category B drugs are characterized by relatively
high interest values, independently of their confidence values.
Let us now consider the high-level W-GARs, which represents the associa-
tion between Category B and Category C drugs (rules R5 and R6 in Table 8).
The W-GARs reported in Table 8 indicate that the strength of the “impli-
cation” {(Drug:Category B)} → {(Drug:Category C )} is significantly higher
than those of the opposite rule. In other words, patients with blood compli-
cations are frequently treated with cardiovascular drugs as well, whereas the
opposite implication is unlikely. A contrasting result is achieved if we con-
sider traditional rules rather than W-GARs (see in Table 9). For example,
the confidence of traditional rule {(Drug:Category C )} → {(Drug:Category
B)} is 50% where the w-confidence of the corresponding W-GAR is only 17%.
The high-confidence W-GAR R5 :{(Drug:Category B)} → {(Drug:Category
C )} represents a strong recurrence among data items (i.e., it holds in 91%
of the cases). Patients who do not adhere to this pattern should be analyzed
separately, because they could represent either anomalous behaviors.
Finally, rules showing the association between a therapeutic group and
the corresponding chemical subgroup are also extracted. An example fol-
lows: {(Drug:ATC2 A11 )} → {(Drug:ATC4 A11CC )}, w-conf=100%. This
rule indicates that 100% of the prescribed vitamins (ATC2 A11 = Vitamins)
are Vitamin D or analogues (ATC4 A11CC = Vitamin D and analogues).
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Vitamin D is particularly recommended to diabetics. Unlike other vitamins,
it is found in very few foods and thus physicians commonly prescribe it as a
supplement.
3.2.2. Analysis of the tf-idf of the prescriptions
Since we are analyzing patients with the same illness (i.e., diabetes), we
are very interested in identifying segments of patients treated with common
treatments because they suffer from similar disease variations or complica-
tions. With this goal in mind, we deemed the simple frequency of drug/ex-
amination prescriptions as not appropriate for this new analysis, because it
targets examinations/drugs prescribed to all patients indifferently. In con-
trast, we aim at identifying peculiar treatment features. Hence, we used the
tf-idf statistics. Strong W-GARs mined from patient data enriched with tf-
idf weights allow us to identify the examinations/drugs that are frequently
prescribed only to a small subset of patients (see Section 2.3).
From the analysis of the extracted high-level rules, it appears that, as
expected, routine examinations and drugs are characterized by relatively low
support values. Hence, very common examinations/drugs are early pruned
or ranked in last place. On the other hand, some low-level rules highlight
specific examinations/drugs that have been prescribed to a small subset of
patients, as thoroughly discussed below.
Weighted generalized rules related to examinations. Table 10 reports a subset
of weighted generalized rules representing worthwhile correlations between
examinations. The patterns were extracted by setting minsup to 50 and
minconf to 0.
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Table 10: Examples of weighted generalized rules related to examinations. Weighting
measure: tf-idf
ID Rule W-Sup W-conf AntInt ConsInt
High-level rules
1 {(Exam:Liver)} → {(Exam:Kidney)} 130.3 73% 0.60 0.45
2 {(Exam:Kidney)} → {(Exam:Cardiovascular)} 125.3 69% 0.60 0.52
Low-level rules
3 {(Exam:ALT )} → {(Exam:AST )} 85.8 98% 0.21 0.58
4 {(Exam:AST )} → {(Exam:ALT )} 85.8 96% 0.21 0.57
5 {(Exam:Triglycerides)} → {(Exam:HDL cholesterol)} 68.4 95% 0.31 0.54
6 {(Exam:HDL cholesterol)} → {(Exam:Triglycerides)} 68.4 94% 0.31 0.53
Rules R3-R6 in Table 10 represent segments of patients with specific treat-
ments. More specifically, rules R3 and R4 cover a segment of patients for
which ALT and AST examinations are frequently prescribed. Both exam-
inations belong to the Liver category. Hence, these W-GARs are likely to
represent diabetics with liver complications. On the other hand, rules R5
and R6 are related to cardiovascular examinations. Since the support of the
aforementioned rules is relatively high (compared to those of the other mined
patterns), we can conclude that both examinations have a high tf-idf and they
are both frequently prescribed to a specific subset of patients. More specif-
ically, the selected rules highlight patients with diabetes and cardiovascular
complications. Note also that the confidence of rules R3-R6 is always higher
than 94% and the same property holds for the opposite implication. Hence,
we can state that, for instance, the ALT and AST prescriptions are related
to a specific subset of patients and both drugs are prescribed, approximately,
in the same quantity.
As expected, rule ranking in order of w-support using tf-idf weight pro-
duces a different ranking with respect to the simple frequency of prescrip-
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tions. For example, let us consider the high-level rules reported in Table 10
(i.e., rules R1 and R2) and the corresponding rules reported in Table 6
(i.e., rules R7 and R8). Note that rule {(Exam:Liver)} → {(Exam:Kidney)}
ranked higher than {(Exam:Kidney)} → {(Exam:Cardiovascular)} with tf-
idf weights, whereas the opposite ranking is achieved using the number of
prescriptions as weighting measure (see Table 6). Therefore, the two mea-
sures produce rather different results and they can be used by domain experts
to address complementary issues.
Weighted generalized rules related to drugs. We also analyzed the associa-
tions among drugs using the tf-idf weights and by setting minsup to 500 and
minconf to 0. In Table 11 a worthwhile subset of selected rules is reported.
Table 11: Examples of weighted generalized rules related to drugs. Weighting measure:
tf-idf
ID Rule W-sup W-conf AntInt ConsInt
Low-level rules
1 {(Drug:ATC4 L04AD)} → {(Drug:ATC4 L04AA)} 798.6 100% 1.00 1.00
ATC4 L04AD = Calcineurin inhibitors
ATC4 L04AA = Selective immunosuppressants
High-level rules
2 {(Drug:Category A)} → {(Drug:Category C )} 105262.4 87% 0.99 0.42
A = Alimentary tract and metabolism
C = Cardiovascular system
The mined rules are representative of diabetics with specific complica-
tions. For example, the first rule reported in Table 11 identifies a sub-
set of patients who are treated with drugs related to transplants, e.g., pa-
tients who have undergone pancreas transplants. Similarly, high-level rule
R2 :{(Drug:Category A)} → {(Drug:Category C )} highlights a segment of
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Figure 2: Impact of the minsup threshold on the average AntInt of the mined rules related
to drugs. Weighting measure: tf-idf. minconf=0
 0.7
 0.75
 0.8
 0.85
 0.9
 0.95
 1
 10000  15000  20000  25000  30000  35000  40000  45000  50000
A
v
e
ra
g
e
 C
o
n
s
In
t
Minimum support threshold
Figure 3: Impact of the minsup threshold on the average ConsInt of the mined rules
related to drugs. Weighting measure: tf-idf. minconf=0
patients with alimentary and metabolism diseases associated with cardiovas-
cular complications.
3.3. Analysis of the algorithm parameters
The W-GAR mining algorithm is driven by two (user-defined) param-
eters: the minimum w-support threshold minwsup and the minimum w-
confidence threshold minwconf . However, setting these parameters properly
could be a challenging task. We performed a set of experiments to analyze
the impact of minwsup and minwconf on the quality of the mined rules
in terms of average AntInt and ConsInt [35]. Due to the lack of space, we
reported only the results achieved on drugs by using tf-idf weights. Similar
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Figure 4: Impact of the minwconf threshold on the average AntInt of the mined rules
related to drugs. Weighting measure: tf-idf. minwsup=1000
results were obtained on the other datasets. Figures 2 and 3 respectively
show the average AntInt and ConsInt values achieved by varying the value
of the minwsup threshold and by setting minwconf to 0 (i.e., no confidence
threshold).
Low-support rules are, on average, characterized by higher AntInt and
ConsInt values with respect to medium- and high-support ones. However,
as shown in Figures 2 and 3, the rule quality decrease achieved by enforcing
medium minwsup values appears to be limited. For example, by enforcing
a support threshold equal to 35000 the average AntInt value is 0.93 and
the average ConsInt value is 0.8, whereas by enforcing a minimum support
threshold equal to 10000 the average AntInt is 0.96 and the average ConsInt
is 0.83. Since the algorithm execution time scales more than linearly with
the number of the enforced support threshold, to limit the computational
complexity of the rule mining process we recommend experts to set medium
minwsup values to perform their analyses. A more detailed analysis of the
execution time taken by the proposed algorithm is reported in Section 3.5.
Figures 4 and 5 respectively show the average AntInt and ConsInt values
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Figure 5: Impact of the minwconf threshold on the average ConsInt of the mined rules
related to drugs. Weighting measure: tf-idf. minwsup=1000
achieved by varying the value of the minwconf threshold and by setting a
fixed minwsup value (1000). The AntInt measure appears to be inversely
correlated with the minwconf value, while the correlation between ConsInt
and minwconf appears to be weaker. However, for both measures the rule
quality is maximal when low minwconf values are enforced. Hence, to avoid
discarding low-confidence yet interesting rules we recommend experts to set
no minconf threshold (i.e., minwconf=0). To ease the manual exploration
of top interesting rules the mined rules can be ranked by decreasing AntInt
and ConsInt values. Examples of low-confidence rules that are particularly
interesting in the analyzed context are given in Section 3.2.1.
3.4. Comparison with different weighted association rule mining approaches
We compared the number and quality of the rules mined by our approach
with those of the rules generated by a previous approach, namely WARM [47].
Note that in [47] each transaction is first weighted by the average of all its
item weights. Then, the rule support is counted by averaging the weights
of all the covered transactions. Hence, the set of rules mined by WARM is
potentially different from those extracted by our approach.
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Figures 6-9 plot the number of rules mined by the W-GAR and WARM
algorithms on the examination and drug datasets with different weighting
measures (i.e., number of prescriptions and tf-idf). Since in WARM the
weight of a transaction depends on the weight of all of its items, all the rules
covering the same transactions have the same support value, even if they
cover a different subset of items. Hence, the support of the rules generated
by WARM is on average higher than those extracted by W-GAR. Indeed,
the number of frequent rules mined by WARM is higher on all datasets and
for all configuration settings. The support count made by WARM appears to
be particularly unreliable when coping with datasets consisting of relatively
large transactions. As an example, in Tables 10 and 12 we reported a subset of
representative rules in common between W-GAR and WARM. They report
the w-support and w-confidence values counted by W-GAR and WARM,
respectively. As expected, the support and confidence values counted by
WARM are higher than those achieved by W-GAR, because all the items in
the transactions are considered. Furthermore, since low- and high-level items
are not differentiated the high-level item weights could bias the support count
of the itemsets consisting of lower-level items.
We also compared the rules mined by the two approaches according to two
established rule quality measures, i.e., AntInt and ConsInt [35]. To perform
a fair comparison, first we set the minimum support threshold values so that
the two algorithms extracted approximately the same number of rules. Then
in Figures 10 and 11 we plotted the AntInt values of the the top 10000 rules in
order of decreasing AntInt and ConsInt values, respectively. The results show
that top ranked W-GARs are on average more interesting than those mined
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Figure 6: Number of mined rules related to examinations. Weighting measure: frequency
of prescriptions
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Figure 7: Number of mined rules related to drugs. Weighting measure: frequency of
prescriptions
by WARMs according to the considered quality measures. Similar results,
omitted due to the lack of space, were achieved on examinations by using
tf-idf weights. Conversely, slightly different results were achieved using the
simple frequency weights. More specifically, with this configuration setting
the quality measures of the top ranked rules extracted by the two approaches
appear to be pretty similar with each other, because since the distribution of
the frequency count values is denser than those of tf-idf values, the differences
in terms of rule quality indices become negligible.
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Figure 9: Number of mined rules related to drugs. Weighting measure: tf-idf
3.5. Execution time
We also analyzed the performance of the proposed approach in terms of
execution time by varying the minimum support threshold. Figure 12 com-
pares the execution times taken by the newly proposed W-GAR algorithm
and the WARM algorithm [47] by varying the minwsup value and by setting
no minwconf threshold (i.e., minwconf=0).
As representative example, we considered the results achieved on the
drugs dataset with the tf-idf weighting measure, because for both algorithms
rule extraction on this dataset takes maximal time compared to the other
datasets and configurations.
The execution times of the two algorithms are roughly comparable when
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high support threshold values are enforced (higher than 40000), while W-
GAR is about 5 times faster than WARM when low support thresholds are
considered (e.g., 10000) . The execution time of W-GAR ranges from few
seconds by enforcing relatively high minwsup values (e.g., 40000) to approx-
imately 15 seconds by enforcing very low support thresholds (e.g., 10000).
The non-linear increase in the execution time is due to the combinatorial
increase of the number of generated item combinations. The execution times
of the W-GAR and WARM algorithms are strongly related with the number
of mined rules (see Figure 9).
As already discussed in Section 3.3, to achieve the best trade-off be-
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Table 12: WARM. Examples of weighted generalized rules related to examinations mined
by using WARM. Weighting measure: tf-idf
ID Rule W-sup W-conf AntInt ConsInt
WARM WARM
High-level rules
1 {(Exam:Liver)} → {(Exam:Kidney)} 122.1 98% 0.60 0.45
2 {(Exam:Kidney)} → {(Exam:Cardiovascular)} 124.6 89% 0.75 0.43
Low-level rules
3 {(Exam:ALT )} → {(Exam:AST )} 113.5 98% 0.21 0.58
4 {(Exam:AST )} → {(Exam:ALT )} 113.5 99% 0.21 0.57
5 {(Exam:Triglycerides)} → {(Exam:HDL cholesterol)} 114.7 97% 0.31 0.54
6 {(Exam:HDL cholesterol)} → {(Exam:Triglycerides)} 114.7 99% 0.31 0.53
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Figure 12: Algorithm execution time related to drugs. Weighting measure: tf-idf.
minwconf=0
tween rule quality and computational complexity experts are recommended
to set medium-value support thresholds (e.g., minwsup=35000). Neverthe-
less, based on the achieved results, all the tested configuration settings seem
to be suitable for performing offline data analyses.
Due to the lack of space we do not report the results of scalability tests
with respect to the number of records and features. However, similar to
traditional generalized rule mining algorithms (e.g., [16, 9, 21, 41]), our algo-
rithm scales linearly with the dataset cardinality and more than linearly with
the average transaction length, because varying the number of transactions
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the data item distribution remains approximately the same, whereas increas-
ing the number of data items the number of generated item combinations
combinatorially increases.
4. Related works
This section compares the proposed approach with the state-of-the-art
related works. Based on the covered topic, the related works are discussed in
separate subsections: (i) pattern mining from medical data, (ii) generalized
(unweighted) association rule mining, and (iii) weighted (non-generalized)
association rule mining.
Pattern mining from medical data. Data mining algorithms have
largely been exploited to discover interesting patterns among medical data,
such as frequent and interesting patterns among patient treatments (e.g., [20,
40]), temporal relationships in temporal clinical data [11, 18, 50], groups
of correlated patients [4, 5, 48], patterns relevant for patient classification
(e.g., [26, 33, 38]). Among the aforementioned approaches, association rules
are worth considering in the analysis of healthcare data to transform huge
amounts of raw data into actionable knowledge. Various kinds of patterns at
different abstraction levels have been considered for analyzing medical data.
Traditional association rules have been exploited in the heart disease sce-
nario [34] to study sick and healthy factors. Three association rule extraction
algorithms (i.e., Apriori [3], Predictive Apriori [39], and Tertius [20]) have
been investigated. In [40], instead, association rules have been exploited to
determine two important diseases in patients diagnosed with essential hyper-
tension, i.e., non-insulin dependent diabetes mellitus and cerebral infarction.
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Unlike [20, 34, 39] in this study we proposed a new kind of patterns, named
weighted generalized association rules (W-GARs), to represent interesting
multiple-level associations among patient treatments.
Preliminary attempts to discover generalized patterns from medical data
have been made in [6, 12, 29]. Specifically, in [29] the authors analyzed
multiple-level co-occurrences among diseases in a public health dataset, while
in [12] generalized rules are used to represent biomedical relationships be-
tween concepts occurring in Medline. The authors in [6] proposed to analyze
multiple-level associations among medical treatments and patient profiles. A
level-wise rule categorization has also been proposed to ease manual result
exploration. Similarly, to ease the exploration of the mined patterns differ-
ent approaches, graph-based strategies (e.g., [36]) have also been proposed.
However, none of the previous approaches is able to cope with data equipped
with item weights. Hence, to the best of our knowledge, this paper is the first
attempt to tackle generalized association rule mining from weighted data. To
address this issue, it proposes a novel type of generalized association rule,
namely the W-GAR. Furthermore, two different weighting measures have
been exploited for weighting data items. Each weighting measure is targeted
to a different use case (e.g., to identify peculiar treatment features, to select
the most appropriate treatments, to check the adherence of prescriptions to
standard guidelines, or to plan healthcare resource allocations).
A parallel research activity has been devoted to taking temporal informa-
tion into account during pattern mining from healthcare data. For example,
the authors in [18] proposed a rule-based approach to discovering complex
temporal relationships in interval-based temporal clinical data, while in [19] a
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sequential pattern mining algorithm has been customized to manage multi-
dimensional healthcare data. Unlike [19, 18] this work does not consider
sequential or temporal patterns.
Generalized association rule mining. A notable research effort has
been devoted to efficiently extracting generalized frequent itemsets and asso-
ciation rules from (unweighted) transactional datasets. The first generalized
frequent itemset mining algorithm has been proposed in [41] in the context of
market basket analysis. It generates itemsets by considering for each item all
its parents in the hierarchy. To avoid generating all the possible candidates in
the taxonomy, the authors in [16, 42, 43] proposed to push (analyst-provided)
constraints into the mining process. Many algorithm optimizations have also
been proposed based on: a top-down hierarchy traversal [21], closed and
maximal generalized itemsets [37] support-driven approaches [9, 13, 14]. Un-
like all the aforementioned approaches, this paper addresses the problem of
mining generalized rules from weighted datasets. Specifically, the goal is
to differentiate between relevant items and not within each transaction by
taking item weights into account during generalized rule extraction.
Weighted association rule mining. To consider the relative impor-
tance of items during the mining process, some attempts to mine association
rules from weighted data have already been made [17, 44, 47, 49]. The ap-
proach presented in [49] is, to the best of our knowledge, the first attempt
to consider item weights during association rule mining. Data items are
enriched with weights denoting item relevance/intensity within each trans-
action. The goal of [49] is to segment of the domain of the item weights in
the dataset and to generate reliable rules containing both items and weight
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intervals. The mined rules have a different expression and semantics with
respect to those mined by our approach. For example, rule drugA[4, 6] →
drugB[3, 5] means that if drug A is prescribed in the quantity between 4
and 6 pills, then drug B is likely to be prescribed in the quantity between
3 to 5 pills. Conversely, our approach does not embeds item weights into
the rule expression, but rather it considers them to compute the main rule
quality indices, e.g., rule drugA → drugB is extracted if drugs A and B are
characterized by high ratings (e.g., high number of prescriptions, high price,
high customer satisfaction).
In [47] the authors defined the weighted support of a rule A → B as
the fraction of the weight of the transactions that contains both A and B
relative to the weight of all transactions, where the transaction weight is
computed as the average of all its item weights. However, since rules are
unlikely to contain all the transaction items the presence of a highly relevant
item in a transaction could bias the support value of the rules that cover
that transaction but do not contain any highly relevant item. Therefore,
in [47] the analysis of the traditional rule quality measures (e.g., support,
confidence [46]) is potentially misleading. Conversely, the approach adopted
in this paper considers only the weights of the items in the rule because they
really matter in rule support counting. Therefore, the extracted rules and
their corresponding quality indices are deemed as more reliable for advanced
analyses.
A parallel effort has been to mining weighted association rules without
preassigned weights. To address this issue, in [44] the analyzed transactional
dataset is represented as a bipartite hub-authority graph and evaluated by
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means of a well-known indexing strategy [28] in order to automate item
weight assignment. The proposed approach is significantly different from
those presented in [28], because in our context of analysis (i.e., patient data
analysis) item weights are given and they represent the number of drug/exam
prescriptions. Therefore, there is no need for inferring item weights with
indexing algorithms. More recently, in [17] the problem of mining infrequent
itemsets from weighted data has also been addressed. Unlike [17, 44, 47,
49] the paper addresses the problem of mining weighted rules from datasets
equipped with taxonomies. To this aim, it proposes a new type of rules
(i.e., W-GARs), which represent associations among weighted data items at
different abstraction levels.
5. Conclusions and future work
This paper presents a new type of generalized association rule, which con-
siders item weights during the rule evaluation process. Item weights measure
the relative item importance within each transaction.
The experiments performed on a real diabetic patient dataset highlight
interesting and actionable correlations among patient treatments. The ex-
tracted knowledge is consistent with the guidelines for diabetes disease [1, 23]
and it is particularly useful for performing advanced data analyses.
As future work, we aim at investigating the applicability of weighted
generalized association rules in other application contexts, including finan-
cial data analysis [30], sensor data analysis [31], genetic data analysis [8], and
social network data analysis [15]. For example, financial data can be straight-
forwardly modeled as weighted data, because for each company/financial in-
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strument several key performance indicators are given and their values vary
over time. For instance, stock prices continuously vary when stock markets
are open. To gain insights into the analyzed data stocks can be generalized
as the corresponding financial sectors or as the corresponding stock markets.
Hence, discovering significant correlations between financial data items at dif-
ferent abstraction levels can be an appealing research issue. Similarly, sensor
readings can be easily integrated into centralized data repositories and mod-
eled as weighted data, where a reading collects the measurements acquired
by all the sensors in a network at a given timestamp. Sensor data can be
analyzed at different temporal and spatial granularities. On the one hand,
experts may would like to analyze the underlying correlations among sensor
data acquired at different time frequencies (e.g., one reading per second, one
reading per day). On the other hand, sensors can be clustered according to
their spatial position in the network topology. To reduce the maintenance
cost of sensor networks the correlations between nearby sensor data can be
analyzed and one representative sensor per group can be maintained. There-
fore, in this context of analysis weighted generalized association rules can
be exploited to study the spatial and temporal correlation between sensor
measurements.
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